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Background: I>-Alanine:Il-alanine ligase is essential for evaluated as reversible inhibitors of the wild-type ligases 
bacterial cell wall synthesis, assembling one of the sub- DdlA and DdlB from Esclzeric-hia co/i and of the mutant 
units used for peptidoglycan crosslinking. The resulting enzymeVanA. K, values were calculated for the first stage 
aminoacyl-n-Ala-),-Ala strand is the Achilles’ heel of van- of inhibitor binding according to a mechanism in which 
comycin-susceptible bacteria; binding of vancomycin to inhibitor competes with I>-Ala for both substrate binding 
this sequence interferes with crosslinking and blocks cell- sites. DdlA is potently inhibited by phosphinates but not 
wall synthesis. A mutant enzyme (VanA) from van- by phosphonates, while DdlB andVanA show little dis- 
comycin-resistant Enterococcus faeciutn has been found to crimination; both series of compounds inhibit DdlB 
incorporate cr-hydroxy acids at the terminal site instead strongly andVanA weakly. 
of I>-Ala; the resulting depsipeptides do not bind van- Conclusions: VanA has greatly reduced affinity for all 
comycin, yet function in the crosslinking reaction. To the ligands studied.The relative affinities of the inhibitors 
investigate the binding specificity of these ligases, we in the reversible binding step are not, however, consistent 
examined their inhibition by a series of substrate analogs. with the substrate specificities of the enzymes. We 
Results: Phosphinate and phosphonate dipeptide analogs propose a mechanism in which proton transfer from the 
(which, after phosphorylation by the enzyme, mimic attacking nucleophile to the departing phosphate occurs 
intermediates in the ligation reaction) were prepared and directly, without intervention of the enzyme. 
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Introduction 
The enzyme n-alanine:D-alanine ligase (E.C. 6.3.2.4) 
carries out a key step in bacterial cell wall biosynthesis 
by establishing the peptide linkage that ultimately pro- 
vides the site of transacylation when the peptidoglycan 
framework is crosslinked. These enzymes are potently 
inhibited by phosphinate dipeptides (such as compound 
1, Fig. l), which are phosphorylated in the active site by 
ATP to produce mimics (compound P-l; Fig. 1) of the 
tetrahedral intermediate in the acylation mechanism 
(Fig. 1) [1,2].Th e ro osal that phosphinate dipeptides p p 
inhibit the ligase via this mechanism was confirmed by 
the recent structural determination by Knox and 
coworkers [3] of the complex formed on combination 
of the Escherichia coli enzyme with the D-Ala-u-Ala- 
phosphinate la and ATP, which produces the mixed 
anhydride P-la and ADP in the active site.The univer- 
sality of this inhibition mechanism has, however, been 
questioned by Al-Bar et al. [4], who found no kinetic 
role for ATP in inhibition of the E. coli Ddl enzyme by a 
phosphonate analog related to la (with R = heptyl). 
The D-stereochemistry of the alanine residues of the 
peptidoglycan allows them to escape the action of most 
proteases and provides a unique recognition element for 
the bacterial enzymes that modulate the crosslinking 
process.These residues also form the recognition site of 
the vancomycin class of glycopeptide antibiotics, which 
interfere with bacterial cell wall biosynthesis by binding 
to the Lys-u-Ala-D-Ala moiety and interfering with the 
assembly and crosslinking processes. Emergence of resis- 
tance to these antibiotics is the result of a dramatic 
alteration in this pathway, as Walsh and coworkers [5] 
have discovered. Not only is a ligase of altered speci- 
ficity required for production of a dipeptidyl unit that is 
not recognized by the antibiotic, (a II-Ala-D-a-hydroxy- 
butyrate depsipeptide, containing an ester linkage 
instead of an amide linkage), but changes in upstream 
enzymes are necessary to provide the altered substrates. 
The mutant ligase from a resistant strain of Entevococcus 
faecium,VanA, has been studied by Walsh and coworkers 
[6,7] and found to have significantly reduced affinity 
for u-Ala compared to wild-type enzymes (Table 1). It 
also shows reduced selectivity for II-Ala compared to 
amino acids with larger hydrophobic sidechains, and, 
most significantly, it accepts cr-hydroxy acids at the 
second (nucleophilic) site; wild-type ligases are not 
known to accept hydroxy acids at the second site. 
To match the altered specificity of the mutant ligase, 
we synthesized some new dipeptidyl phosphorus 
analogs (see Fig. 1) and evaluated them as inhibitors of 
both the wild-type and the mutant ligases. In addi- 
tion to the known II-Ala-u-Ala phosphinate la, we 
synthesized the phosphinates corresponding to II-Ala- 
I>-Leu (compound lb) and D-Ala-n-Phe (compound 
lc) and the phosphonates corresponding to D-Ala-D- 
lactate (compound 2a) and D-Ala-n-ar-hydroxybutyrate 
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Fig. 1. Mechanism and inhibition of o-Ala:o-Ala ligase. (a) 
Mechanism of the ligase reaction. Phosphorylation of the carboxyl 
donor is followed by nucleophilic attack by the amino donor to 
give a tetrahedral adduct; tautomerization by proton transfer leads 
to an intermediate that loses inorganic phosphate (Pi) and forms 
the o-Ala-D-Ala dipeptide. (b) Structures of phosphinate (1) and 
phosphonate (2) inhibitors. (c) Mechanism of phosphinate inhibi- 
tion. Phosphorylation of the phosphinate 1 leads to the mixed 
anhydride P-l, a mimic of the tetrahedral intermediate for dipep- 
tide formation (see [a), above); the phosphonates 2a and 2b are 
expected to react the same way. 
(compound 2b).We studied the phosphonate com- 
pounds to examine the specificity of theVanA ligase for 
ester bond formation. 
Kinetic analysis of D-Ala-D-Ala ligase is not straightfor- 
ward.The two amino acids to be joined occupy distinct 
binding sites on the enzyme that have different affinities 
for D-Ala.The Michaelis constants observed for the first 
, 
Table 1. Kinetic constants for D-Ala-b-Ala tigasesa 
Bacterium k cat 
(min-l) 
K,, (D-da) K,, @-Ata) 
(I-N WV 
S. typhimurium 644 1.9 540 
E. co/i Ddl A 444 5.7 550 (1200”) 
E. coli Ddl B 1018 3.3 1200 (1700h) 
E. faecium (VanA) 295 3400 38 000 (25 OOOh) 
“From [6,24] 
“This work. 
II-Ala (K,,,t, Fig. 2), which is converted to the mixed 
anhydride by ATP, are typically 100-IOOO-fold lower 
than those for binding of the second, nucleophilic sub- 
strate (Km2) [6]. Th e rate expression that describes this 
process is given in equation 2A (Fig. 2b) [8]. 
The disparate affinities of the two D-Ala sites complicate 
the analysis of inhibitor binding by the typical competi- 
tive methods, particularly for inhibitors that occupy both 
of these subsites. At concentrations of n-Ala low enough 
to permit competition between the inhibitor and n-Ala 
for the first site ([[)-Ala] = 1 PM), so little is bound to 
the second site that the reaction rate is very slow 
(-l/1000 of V,,,J; as a result, the initial, reversible 
binding step cannot be monitored under these condi- 
tions. At concentrations of D-Ala high enough to occupy 
both sites and give reasonable reaction rates ([II-Ala] y 1 
mM), however, inhibition is virtually overwhelmed by 
saturation of the first site. 
For the dipeptidyl phosphinate and phosphonate 
inhibitors, the analysis is further complicated by a bi- 
phasic inactivation process; the degree of inhibition 
increases with time, presumably as the phosphinate (or 
phosphonate) is converted to the more tightly-bound, 
phosphorylated species, P-l 19-l 11. The ultimate affin- 
ity of this or related compounds in the ternary complex 
with enzyme and ADP has not been determined accu- 
rately; recovery of activity is very slow and it is not 
known whether dissociation of the complex is truly a 
mirror of the association process. An overall inhibition 
constant, K1*, f or association of the P-l complex has d’ 
been reported for the tightened complex of an E. coli 
E.ATP i 
k cat 
K 
E.ATP.D-Ala, i E.ATP.D-Ala,.D-Ala z - 
D-Ala-D-Ala + 
ml K m2 
E+ADP+Pi 
(b) 
dP V max [D-Alal 
- =v= WV 
dt 
Krnl Km2 + K, [D-Ala] + [D-Ala12 
Fig. 2. Binding of substrate to the ligases 
occurs in two steps. (a) The stages of the 
reaction and (b) the overall rate expres- 
sion reflecting the two-step substrate- 
binding process are shown. 
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Fig. 3. Kinetic analysis of inhibitor (I) 1 
bGding using the’ assumption that 
inhibitors bind to the ligase*D-Ala, com- 
plex. (a) The proposed reaction pathway 
and (b) the overall rate expressions that 
apply are shown. 
‘z.ATp c E*,bTp*~-Ala, c k ‘at E*ATP.D-Ala,9Ala, - D-Ala-D-Ala + 
K ml K 11 rnL E +ADP+P, L 
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I 
Ii 
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/ 6) 
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v= 
K,1%12 + cl2 
[D-Ala] l+ $ + [D-Ala]’ i ,I 
V [D-Ala] 
V” max when [D-Ala] = K,, 
K m2 
(3A) 
(3B) 
ligase with the heptyl-substituted analog of compound 1 
(with R = nC7H15), but this system apparently does not 
involve phosphoryl transfer to the inhibitor [4]. 
Discussion 
Mode of inhibition 
Results 
Phosphinates la-c and phosphonates 2a and 2b were 
evaluated as inhibitors for three ligase enzymes: the 
DdlA and DdlB enzymes from E. coli and the VanA 
mutant from E. faecium. We followed the lead of previous 
groups [4,8-10,12-151 and determined inhibitor affinity 
in the readily reversible phase of the inactivation process 
using a simple Dixon plot to calculate binding constants 
at [I,-Ala] = Ktn2.This analysis is derived from equation 
3B (see Fig. 3b), which corresponds to inhibitor compe- 
tition with the second D-Ala substrate as represented by 
the reaction mechanism in Figure 3. We therefore desig- 
nate these constants as Ki’ values in Table 2. Since the 
relevant binding event is that of the inhibitor to the 
free enzyme, not binding of the inhibitor to the 
enzyme-II-Ala1 complex (see the discussion below), we 
also calculated inhibition constants using equation 4C 
(see Fig. 4b). Th‘ 1s scheme represents competition with 
both D-Ala substrates according to the reaction mecha- 
nism in Figure 4; the K1 values derived in this manner 
are provided in Table 3. 
The rapidly reversible step of inhibitor binding has 
been analyzed previously at [u-Ala] = Kma, applying 
the Dixon analysis [18] to equation 3B [9]. The Ki’ 
values of Table 2 were determined in this manner 
and thus can be compared directly to the previous 
results. Equation 3B is equivalent to equation 3A when 
[D-Ala] = Km2 ^I 1000 x K,,,,, since the additional term 
in the denominator, K,,K,,l,, is insignificant under these 
conditions. These expressions are valid for calculation of 
inhibition constants for binding of an inhibitor that is 
only in competition for the second D-Ala binding site, 
leading to formation of an enzyme-n-Ala1 *inhibitor 
complex from enzyme*n-Ala1 (Fig. 3). 
It is unlikely, however, that the dipeptidyl phosphinates 
and phosphonates bind exclusively or even primarily to 
the enzyme*D-Ala1 complex. These inhibitors are bisub- 
strate analogs that are readily phosphorylated in the 
enzyme active site as alternative substrates to the tightly 
Table 2. Reversible inhibition of ligases by phosphinate and 
phosphonate analogs: binding to ligase*D-Ala, complex.a 
In this study, we did not determine the time course of 
inhibitor phosphorylation, which is the second step in 
the inactivation mechanism, or measure the affinity of 
these final complexes. Preliminary evidence suggests, 
however, that the phosphonates come to equilibrium 
more rapidly than the phosphinates, reflecting either 
incomplete phosphorylation in the active site, or more 
rapid reversal of the phosphorylation step. This latter 
explanation is consistent with the differences observed 
for phosphinate and phosphonate inhibitors of gluta- 
mine synthetase, which also undergo phosphorylation in 
DdlAb DdlBb VanAb 
D-Ala[PO,&H,]D-Ala (la) 27 4 60 
o-Ala[P02-CH*]D-Leu (1 b) 9 4 23 
o-Ala[PO,-CH,jo-Phe (lc) 3 3 11 
D-Ala[PO,$]D-La@ (2a) 800 18 130 
D-Ala[PO,-O]D-HbuF (2b) 1000 20 100 
aKi’ values in FM calculated according to equation 38 as 
described in [9]. 
bK,2 (DdlA) = 1.2 mM; K,, (DdlB) = 1.7 mM; K,, (VanA) = 
25 mM. 
the enzyme active site 116,171. 
CLac = lactate, Hbut = a-hydroxybutyrate. 
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VE when [D-Ala] >> K,,, (40 
K 
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bound II-Ala; this phosphorylation logically requires the 
aminoethylphosphinyl moiety of the inhibitors to bind 
in the first u-Ala site, as indicated in Figure 4. Moreover, 
if the inhibitors were accepted as alternative ligands at 
the second u-Ala site, they would logically be ligated to 
II-Ala, and substrate turnover, rather than enzyme inhi- 
bition, would be expected. The most compelling evi- 
dence against the notion that these inhibitors bind to 
the ligase*u-Ala, complex is the fact that both the sub- 
strate specificity of the various ligases and the three- 
dimensional structure of the E. coli enzyme suggest that 
molecules as large as the dipeptidyl inhibitors cannot fit 
into the active site in the presence of D-Ala,. We there- 
fore conclude that these inhibitors probably compete 
with both n-Ala substrates for binding to the enzyme. 
Inhibitor binding in competition with both II-Ala sub- 
strates, according to the scheme in Figure 4, is described 
Table 3. Reversible inhibition of ligases by phosphinate and 
phosphonate analogs: binding to free enzyme.a 
DdlAb DdlBb VanAb 
o-Ala[PO,-CH,]o-Ala (la) 55 3 4100 
o-Aia[PO,-CH,]o-Leu (1 b) 18 3 1600 
o-Ata[P02&H2]o-Phe (1~) 6 2 750 
o-ALa[PO,-O]o-LacC (2a) 1600 12 8800 
D-Ala[PO,&I]o-HbutC (2b) 2000 13 6800 
“K, values in nM calculated according to equation 4C; K,, 
(DdlA) = 6 pM; K,, (DdlB) = 3 pM; K,, (VanA) = 3 mM, taken 
from [5] 
hK,2 (DdlA) = 1.2 mM; K,, (DdlB) = 1.7 mM; K,, (VanA) = 
25 mM. 
CLac = lactate, Hbut = cY-hydroxybutyrate. 
Fig. 4. Kinetic analysis of inhibitor (I) 
binding to the free enzyme. (a) The pro- 
posed reaction pathway and (b) overall 
rate expressions that apply are shown. 
by equation 4A (Fig. 4b). This expression can be 
rearranged to equation 413, and simplified to the 
Michaelis-Menten relationship shown in equation 4C, 
recognizing that the ratio K,,l/[D-Ala] is small rela- 
tive to 1 under the assay conditions, that is, when 
[D-Ala] = Km, ^I 1000 x Kn,, Thus the Ki’ values deter- 
mined from Dixon analysis of equation 3B must be cor- 
rected by the Kln,/[tl-Ala] term of equation 4C to 
obtain the inhibition constants, K,, for binding to free 
enzyme (Table 3).The two modes of analysis (Figs 3 and 
4) only affect comparisons between the three enzymes; 
comparisons between inhibitors for the same enzyme 
are independent of the model used, since the factor 
K,,,/[rl-Ala] drops out of a ratio of Ki values. 
Inhibitor specificity 
The three ligases differ in their selectivities for the side 
chain of the carboxy-terminal moiety, as well as in their 
sensitivity to replacement of the methylene linkage of 
the phosphinates with the oxygen of the phosphonates. 
The oxygen was incorporated to provide a better 
mimic for theVanA mutant, which has been shown to 
catalyze ester formation from cx-hydroxy acids in pref- 
erence to amide formation from II-Ala [6,7]. 
(Comparison with the nitrogen-linked, dipeptidyl 
phosphonamidates is not possible, since these com- 
pounds are not stable at neutral pH [14].) It is interest- 
ing, therefore, that the phosphonates are weaker 
inhibitors than the phosphinates for all three ligases 
studied, although the least discrimination is seen with 
DdlB, not with the VanA mutant. There is little differ- 
ence among the three enzymes in their selectivity for 
carboxy-terminal sidechains: all prefer the hydrophobic 
phenylalanyl and leucyl moieties over the alanine 
methyl group, although, again, the least selectivity is 
shown by DdlB. The major difference in substrate 
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Fig. 5. A stereoview of the hydrogen- 
bonding network near P-la in the DdlB 
active site. Potential hydrogen bonds are 
shown as dashed lines. Carbon atoms 
are black, oxygens white, nitrogens grey 
and phosphorus hatched. 
Serl50 Tvr216 Serl50 Tvr216 
selectivity between the wild-type ligases and VanA 
appears to be in the D-Ala, site. 
The recently determined structure of the complex 
between the E. coli DdlB ligase and compound P-la, 
the phosphorylated form of the D-Ala-D-Ala phosphi- 
nate la, provides a starting point for structural analysis 
of the effects on inhibitor binding (Fig. 5) (31. Although 
the inhibitor in this complex is already in the tight- 
binding form due to phosphorylation, the structure 
nonetheless provides an indication of the active-site 
residues that may interact with the linking atom (the 
nitrogen of the amide link in the case of dipeptide for- 
mation, or the oxygen of the ester link in depsipeptide 
formation). The amino-acid side chain of DdlB that is 
closest to the methylene linkage in compound P-la is 
Tyr216, with an O-C distance of 3.5 A. In the actual 
substrate complex (N in place of C), these atoms would 
be within hydrogen-bonding distance, and their inter- 
action could be significant in substrate binding. Many 
of the active-site residues of DdlB are preserved in the 
DdlA enzyme and in theVanA mutant, with the signifi- 
cant exception ofTyr216, which is replaced by Lys in 
VanA. As Knox and coworkers point out (31, this muta- 
tion is probably responsible for the preference of the 
VanA enzyme for hydroxy acids over amino acids as the 
nucleophilic substrate. 
Enzyme mechanism 
One of the unresolved aspects of the acylation step in 
the ligase mechanism is how the proton(s) are trans- 
ferred from the attacking nucleophile to the departing 
phosphate [3]. The initial proposal that the phenolic 
oxygen of Tyr2 16 is responsible has been ruled out by 
Shi and Walsh [ll], who found that the Tyr216+l?he 
mutant of DdlB is almost as active catalytically as the 
native enzyme. They point out that a significant fraction 
of II-Ala is deprotonated in the pH range where the 
enzyme is active, and, moreover, that the difference 
in affinity at the two r>-Ala binding sites can easily 
accommodate a mechanism in which t)-Ala, binds as 
the zwitterion and II-Ala, binds as the anion. 
There may not be any intermediary in the transfer of the 
proton from the nucleophile to the phosphate (Fig. 6a). 
If tl-Alaz binds as the anion, proton transfer is not 
required until the tetrahedral intermediate tautomerizes 
prior to release of inorganic phosphate (Fig. 1). In the 
complex of DdlB with adduct P-la, one of the phos- 
phate oxygens is only 3.26 A away from the methylene 
(a) 0- 
O+OH 
I 
6) o- - 
O+/O -,:’ 
6 1 +H 3 
N,(Lys216) 
+H3N +H3N 
Fig. 6. Proposed mechanisms for the ligation reactions carried out by (a) wild-type ligases and (b) VanA. In both cases, o-Ala, binds to 
the first substrate-binding site as the zwitterion and becomes phosphorylated (see Fig. 1). In the case of the wild-type ligases (a), the sec- 
ond D-Ala binds as the anion and therefore does not need to be deprotonated prior to nucleophilic attack. After formation of the tetra- 
hedral adduct, proton transfer from the nucleophilic nitrogen to the departing phosphate occurs directly, without involvement of the 
enzyme. In the case of VanA (b), the side chain closest to the nucleophile, Tyr216, is replaced with a Lys residue; the proximity of the 
cationic side chain of Lys216 acidifies the hydroxyl group of the cY-hydroxy acid substrate, enabling the phosphate to deprotonate it and 
induce nucleophilic attack. No subsequent proton transfers are required to complete formation of the depsipeptide. 
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carbon that corresponds to the nitrogen of D-Ala, in the 
tetrahedral adduct, a distance that would permit proton 
transfer (31. In the VanA mutant, the phosphate oxygen 
may also be the proton acceptor that activates the 
hydroxyl group of the cw-hydroxy acid (Fig. 6b); the 
phosphate is nominally the strongest base in the vicinity, 
and it must pick up a proton to allow decomposition of 
the tetrahedral adduct. In this mechanism, Lys216 serves 
to acidify the hydroxyl group electrostatically, as previ- 
ously suggested [3]. (See [lo] for another case in which 
an enzyme induces the substrate phosphate group to 
serve as the catalytic base.) 
Can we rationalize the modest differences in binding 
affinity between the phosphinate and phosphonate 
inhibitors in the light of the structural observations and 
the above mechanistic proposals? The ability to discrimi- 
nate between the methylene- and oxygen-linked 
inhibitors is independent of the residue at position 216. 
The disparate enzymes DdlB and VanA show similar, 
four- to five-fold preferences for the phosphinates over 
the phosphonates, whereas DdlA and DdlB, which both 
have Tyr at position 216, differ significantly in their ability 
to bind the phosphonates. Thus, these differences appear 
to be unrelated to substrate preference and enzyme 
mechanism. Moreover, previous experience with phos- 
phinate and phosphonate peptidase inhibitors has shown 
that differences in solvation between these inhibitors are 
at least as important in determining reversible binding 
aflinities as their specific active site interactions 1201. 
Comparison between enzymes 
The greatest difference between the three ligases is their 
absolute affinity for the inhibitors, as determined by the 
Ki values (Table 3).The drastically weaker binding of the 
inhibitors to theVanA mutant mirrors the reduced affin- 
ity of the enzyme for the substrates, especially at the 
II-Ala1 site (Table l).This reduction in inhibitor affinity 
for VanA is not as apparent from Ki’ values (Table 2), 
since those analyses do not take into account competi- 
tion with substrate binding at the I2-Ala, site.As a start- 
ing point for mutation, the wild-type ligases have 
considerable affinity to sacrifice at the D-Ala, site, since 
the Kn,l values of the enzymes for n-Ala are about 
200-400-fold lower than the Km2 values. Indeed, the 
greatest change in substrate affinity for the VanA mutant 
has actually occurred at the II-Alai site, even though 
altered specificity at the D-da2 site, allowing hydroxy 
acids to function as substrates, is the ultimate result of the 
mutation.The large reduction in binding affinity to the 
VanA mutant for all the phosphorus-containing analogs 
has significant implications for the design of inhibitors 
specific for this enzyme. 
Significance 
D-Alanine:D-alanine ligase is an enzyme that iS 
essential for bacterial cell wall synthesis. The 
subunit it produces is incorporated into a penta- 
peptide precursor of the peptidoglycan; this 
pentapeptide is the target of the antibiotic van- 
comycin. We have studied the specificity of 
inhibitor binding to wild-type (DdlA and DdlB) 
and to a mutant version (VanA) of this ligase. 
VanA, which is from a vancomycin-resistant bac- 
terium, forms the D-Aa-D-hydroxybutyrate depsi- 
peptide instead of D-Ala-D-Ala; incorporation of 
the depsipeptide unit in the growing cell wall 
leads to a modified peptidoglycan that is not 
complexed by vancomycin, thus allowing the 
host to escape the action of this antibiotic. Of 
the two series of inhibitors studied, the phosphi- 
nates are known to afford mimics of the tetra- 
hedral intermediate of the wild type ligases; the 
phosphonates, in turn, were devised to mimic 
that for depsipeptide formation. 
Inhibitors of this type have previously been 
analyzed as competitors with D-Ala, only for 
binding to the second substrate site in the 
rapidly reversible stage of inhibition. When evalu- 
ated as competitors for both D-Ala-binding sites, 
the phosphinates appear to bind the native DdlA 
and Ddlb enzymes three orders of magnitude 
more tightly than when assessed with the previ- 
ous analysis. This difference is considerably less 
for the VanA mutant. Although VanA has altered 
substrate specificity at the second binding site, 
the major differences seen between this enzyme 
and the wild-type ligases are changes in substrate 
and inhibitor binding at the D-Ala1 site. 
Interestingly, discrimination between phosphi- 
nate and phosphonate inhibitors does not paral- 
lel that between amino acid and hydroxy acid 
substrate selectivity. 
A novel mechanism is proposed for the wild- 
type and mutant ligases, in which proton trans- 
fer from the attacking nucleophile to the 
departing phosphate occurs directly, without 
involvement of an enzymatic functional group. 
The fact that no enzymatic side chain is 
involved explicitly may explain why mutation 
from an N-acylase to an 0-acylase is relatively 
straightforward, only requiring alteration of the 
electrostatic characteristics of the active site. 
Materials and methods 
Synthesis 
Experimental procedures for preparation of compounds la-c 
and 2a,b and the details of their characterization are provided in 
the Supplementary material. A revised synthesis of the I)-Ala-l)- 
Ala phosphinate la was developed and extended to the prepara- 
tion of the r)-Leu and n-Phe analogs lb and 1~ (Fig. 7). 
Phosphonous acid 3 was prepared and resolved by the reported 
procedure [21].The n-enantiomer was converted to the trivalent 
tautomer by silylation, and added to the appropriate a-aIkyl- 
acrylate esters to give the coupled phosphinates as mixtures of 
four diastereomers. The phosphonate derivatives were prepared 
from the same phosphonous acid using an in ritlr activation and 
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I) LiOH, CHJCN ‘X la-c 
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2a, b J 1) LiSPr, HMPA 
2) HZ, Pd/C 
Fig. 7. Synthesis of inhibitors (see Materials and methods for details). 
coupling protocol [22]. Diastereomeric phosphinates were 
resolved by digestion with the serine protease subtilisin 
Carlsberg; isomers with the L-configuration at the terminal 
center were hydrolyzed, allowing separation from the neutral, 
u,D-diastereomers. In the case of the phosphinates, simple alka- 
line hydrolysis and hydrogenolysis removed the esters and nitro- 
gen protecting group. Selective cleavage of the phosphonate 
esters was achieved with lithium propanethiolate [23] prior to 
hydrogenolysis of the benzyl carbamate (Cbz) moiety. All of the 
inhibitors were obtained as the zwitterions as stable white solids. 
Enzyme assays 
The standard buffer used in all assays was 0.1 M Tris, 10 mM 
MgCl,, and 10 mM KC1 in doubly distilled water.The buffer 
was adjusted to pH 7.8 at room temperature and passed 
through a Millipore filter (0.45-km pore size) prior to use.The 
buffer used in assays with E. faecium VanA was prepared in a 
similar manner except the pH was adjusted to 8.6 at room tem- 
perature. Assays were performed on a Uvikon 860 spectro- 
photometer at 37 “C, and data were analyzed with Kaleidagraph 
(Version 3.0.1, Adelbeck Software). 
Determination of Km2 for the ligases 
The assay solution included enzyme (-1.5 p,g ml-’ for DdlA, 
-0.5 kg ml-’ for DdlB, VanA concentration undetermined), 
5 mM ATP, 50 bg ml-’ lactate dehydrogenase, 0.14 mg ml-’ 
pyruvate kinase, 5 mM NADH, 125 mM phosphoenolpyruvate 
(PEP), and n-Ala in a final volume of 1 ml.The concentration 
of D-Ala was varied from 0.25-4 x K,,. The enzymatic rate 
was determined by monitoring the UV absorbance change at 
340 nm to less than 10 % consumption of substrate, and the 
data was analyzed via non-linear regression according to equa- 
tion 4A, using the K,, values reported by Wright and Walsh 
[5]. Values for Km, determined by non-linear regression do 
not differ significantly from those determined previously by 
Lineweaver-Burk analysis (Table 1) [24]. 
inhibition of the ligases 
The E. roli enzymes DdlA (-1.4p.g ml-‘) and DdlB (-0.5 
p,g ml-‘) and the E. faecicrm ligase VanA (-0.8 pg ml-‘) were 
assayed in the presence of 3 mM ATP, 10 pg ml-l lactate de- 
hydrogenase, 0.03 mg ml-’ pyruvate kinase, 5 mM NADH, 
125 mM PEP, u-Ala at a concentration equal to K,,, and the 
inhibitor in a total volume of 1 ml at 37 “C. The enzymatic 
rate was determined by monitoring the UV absorbance change 
at 340 nm. 
Supplementary material available 
Experimental details for the preparation of compounds la-c 
and 2a,b; kinetic plots for determination of Ki values. 
Acknowledgements: We thank Professor Chris Walsh and DrYian 
Shi (Harvard Medical School) and Dr Gerry Wright 
(McMaster University) for generous gifts of the ligases and, 
along with Dr James K. Knox (University of Connecticut), for 
fruitful discussions. This work was supported by grant no. 
GM46627 from the National Institutes of Health. 
References 
I. Mullins, L.S., Zawadzke, L.E., Walsh, C.T., & Raushel, F.M. (1990). 
Kinetic evidence for the formation of o-alanyl phosphate in the 
mechanism of o-alanyl-o-alanine ligase. /. Biol. Chem. 265, 
8993-8998. 
2. Parsons, W.H. et al. & Busch, R.D. (1988). Phosphinic acid inhibitor 
of D-alanyl-o-alanine ligase. 1. Med. Chem. 31, 1772-l 778. 
3. Fan, C., Moews, P.C., Walsh, C.T., & Knox, J.R. (1994). Vancomycin 
resistance: structure of D-alanine:D-alanine ligase at 2.3 A resolution. 
Science 266,439443. 
4. Al-Bar, O.A.M., O’Connor, C.D., Giles, l.c., & Akhtar, M. (1992). 
D-Alanine:D-alanine ligase of Eschericbia co/i. Expression, purifica- 
tion, and inhibitory studies on the cloned enzyme. Biocbem. /. 282, 
747-752. 
5. Wright, C.D., & Walsh, C.T. (1992). D-Alanyl-D-alanine ligases and 
the molecular mechanism of vancomycin resistance. Act. Gem. 
Res. 25, 468-473. 
6. Bugg, T.D.H., Dutka-Malen, S., Arthur, M., Courvalin, P., & Walsh, 
C.T. (I 991). Identification of vancomycin resistance protein VanA as 
a o-alanine:D-alanine ligase of altered substrate specificity. 
Biochemisky 30, 2017-2021. 
7. Bugg, T.D.H., Wright, G.D., Dutka-Malen, S., Arthur, M., Courvalin, 
P., & Walsh, C.T. (1991). Molecular basis of vancomycin resistance 
in Enterococcus faecium BM4147: biosynthesis of a depsipeptide 
peptidoglycan precursor by vancomycin resistance proteins VanH 
and VanA. Biochemistry 30, 10408-l 0415. 
8. Neuhaus, F.C., & Lynch, J.L. (1964). The enzymatic synthesis of 
o-alanyl-o-alanine. III. On the inhibition of o-alanyl-D-alanine syn- 
thetase by the antibiotic D-cycloserine. Biochemistry 3, 471-480. 
9. Duncan, K., &Walsh, C.T. (1988). ATP-dependent inactivation and 
slow binding inhibition of Salmonella typhimurium D-alanine: 
D-alanine ligase (ADP) by (aminoalkyl)phosphinate and amino- 
phosphonate analogues of D-alanine. Biochemistry 27, 3709-3714. 
10. McDermott, A.E., Creuzet, F., Griffin, R.C., Zawadzke, L.E., Ye, Q., 
& Walsh, C.T. (1990). Rotational resonance determination of the 
structure of an enzyme-inhibitor complex: phosphorylation of an 
(aminoalkyl)phosphinate inhibitor of o-alanyl-o-alanine ligase by 
ATP. Biochemistry 29, 5767-5775. 
I I. Shi, Y., & Walsh, CT. (1995). Active site mapping of Escherichia co/i 
D-Ala-D-Ala ligase by structure-based mutagenesis. Biochemistry 34, 
2760-2776. 
12. Chakravarty, eta/., & Mellin, T.N. (1989). (3.Amino-2-oxoalkyl)phos- 
phonic acids and their analogues as novel inhibitors of D-alanine:D- 
alanine ligase. /. Med. Chem. 32, 1886-l 890. 
13. Duncan, K., Faraci, W.S., Matteson, D.S., &Walsh, CT. (1989). ATP- 
dependent inactivation and slow binding inhibition of Salmonella 
44 Chemistry & Biology 1996, Vol 3 No 1 
typbimurium o-alanine:o-alanine ligase (ADP) by (aminoalkybphos- 
phinate and aminophosphonate analogues of o-alanine. Biochemistry 
28,3541-3549. 
14. Lacoste, A., Chollet-Cravey, A., Vo-Quang, L., Vo-Quang, Y., & Le 
Goffic, F. (1991). Time-dependent inhibition of S. faecalis o-alanine: 
o-alanine ligase by ol-aminophosphonamidic acids. Eur. J. Med. 
Chem. 26,255-260. 
15. Lacoste, A., Poulsen, M., Cassaigne, A., & Neuzil, E. (1979). 
Inhibition of o-alanyl-o-alanine ligase in different bacterial species 
by amino phosphonic acids, Curr. Microbial. 2, 113-l 17. 
16. Johnson, CR., Boettcher, B.R., Cherpeck, R.E., & Dolson, M.C. 
(1990). Design and synthesis of potent inhibitors of glutamine syn- 
thetase 1. Cyclic analogs of phosphinothricin. Bioorg. Gem. 18, 
154-l 59. 
17. Logusch, E.W., et al., & Schineller, J. B. (1990). Inhibition of 
Escbericbia co/i glutamine synthetase by OL- and y-substituted 
phosphinothricins. Biocbemistry29, 366-372. 
18. Dixon, M. (1972). The graphical determination of K, and K,. 
Biocbem. J. 129, 197-202. 
19. Bender, S.L., Widlanski, T., & Knowles, J.R. (1989). Dehydroquinate 
synthase: the use of substrate analogues to probe the early steps of 
the catalyzed reaction. Biochemistry 28, 7560-7572. 
20. Morgan, B.P., Scholtz, J.M., Ballinger, M.D., Zipkin, I.D., & Bartlett, 
P.A. (1991). Differential binding energy: a detailed evaluation of the 
influence of hydrogen-bonding and hydrophobic groups on the Inhi- 
bition of thermolysin by phosphorus-containing inhibitors. J. Am. 
Cbem. Sot. 113, 297-307. 
21. Baylis, E.K., Campbell, C.D., & Dingwall, J.C. (1984). l-Amino 
alkylphosphonous acids. Part 1. lsosteres of the protein amino acids. 
J. Gem. Sot. i/l, 2845-2853. 
22. Sampson, N.S., & Bartlett, P.A. (1988). Synthesis of phosphonic acid 
derivatives by oxidative activation of phosphinate esters. 1. Org. 
Cbem. 53,4500-4503. 
23. Bartlett, P.A., & Johnson, W.S. (1970). An improved reagent for the 
0-alkyl cleavage of methyl esters by nucleophilic displacement. 
Tetrahedron Lett., 44594462. 
24. Zawadzke, L.E., Bugg, T.D.H., & Walsh, C.T. (1991). Existence of 
two n-alanine:o-alanine ligases in bcbericbia co/i: cloning and 
sequencing of the dd/A gene and purification and characterization 
of the DdlA and DdlB enzymes. Biochemistry 30, 1673-l 682. 
Received: 20 Ott 1995; revisions requested: 8 Nov 1995; 
revisions received: 13 Dee 1995. Accepted: 21 Dee 1995. 
